Pharma business model broken, survey says

Nearly 70 percent of pharmaceutical leaders say that the business model for companies selling drugs is broken and needs remodeling, according to a survey conducted by Strategy&, and Philadelphia's National Analysts Worldwide.

The biggest challenge facing pharma companies is pricing pressure brought on by governments facing tight budgets. The logical next biggest challenge is the need to justify why a drug is better than the industry standard.

The full survey report is here.